Julie Hartman
Family · Murrieta, CANPI 1770222184
Payments from drug & device makers
Across 105 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$636
- Lilly USA, LLC$281
- Amgen$277
- AstraZeneca$142
- Novo Nordisk$108
- Pfizer$78
- plus $385 from 14 others
What the payments were for
- Food & beverage$1,907100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $636 |
| Lilly USA, LLC | 21 | $281 |
| Amgen | 12 | $277 |
| AstraZeneca | 8 | $142 |
| Novo Nordisk | 6 | $108 |
| Pfizer | 4 | $78 |
| Optinose US, Inc. | 3 | $66 |
| Boehringer Ingelheim | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Merck | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Exact Sciences | 1 | $24 |
| GSK | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Edwards Lifesciences | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$110
How this compares
$1,907 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 21 | $24,855 |
| JardianceEmpagliflozin | 18 | $24,192 |
| CreonLipase/Protease/Amylase | 12 | $16,840 |
| MounjaroTirzepatide | 14 | $14,934 |
| EliquisApixaban | 20 | $13,006 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $2,863 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,459 |
| Rosuvastatin Calcium | 96 | $1,188 |
| Levothyroxine Sodium | 96 | $1,153 |
| ProgesteroneProgesterone, Micronized | 18 | $1,000 |
| Metformin Hcl | 91 | $916 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $834 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 43 | $731 |
| Bupropion XlBupropion Hcl | 19 | $584 |
| Losartan Potassium | 84 | $560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $108 | $24,85521 claims |
| Boehringer IngelheimJardiance | $42 | $24,19218 claims |
| AbbVieCreon, Synthroid | $636 | $16,98123 claims |
| Lilly USA, LLCMounjaro | $281 | $14,93414 claims |
| PfizerEliquis | $78 | $13,00620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,634 family providers in California.
Other family in Murrieta
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.